SynGenSys Introduces Liver.SET Synthetic Promoter Library for Liver-specific Gene Expression for in vivo Gene Therapies SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and…
CorriXR Therapeutics Publishes Peer-Reviewed Preclinical Study Demonstrating CRISPR-Based NRF2 Editing Restores Chemosensitivity in Treatment-Resistant Solid Tumors CorriXR Therapeutics, an oncology-focused biotherapeutics company developing next-generation genetic medicines to overcome drug resistance…
CareDx Announces Publication of Third SHORE Study in JHLT, Demonstrating the Strong Prognostic Value of HeartCare for Heart Transplant Recipients CareDx, Inc., a pioneer in precision medicine dedicated to improving…
St. Jude and ALSAC welcome new board members whose diverse experience will help advance research, treatment, and global impact. St. Jude Children’s Research Hospital® and ALSAC—the organization dedicated to fundraising…
Healthcare teams can now summon patient-specific evidence inside Microsoft Teams for streamlined, evidence-driven care. Atropos Health, a leading innovator in real-world evidence (RWE) generation, has taken a significant step forward…
New report highlights strong growth fueled by wellness trends, aging demographics, and innovation in supplement formulations. the “United States Dietary Supplements Market Report by Form, Type, Application, End Use, Distribution…
High-Level Federal Engagement Marks a New Era for Food Allergy Research In a historic show of federal alignment, top leaders from the nation’s health agencies joined the Food Allergy Fund…
Pediatric Interventional Cardiology Market to Reach USD 4.34 Billion by 2033, Driven by Rising Congenital Heart Disease Cases and Technological Advancements The global pediatric interventional cardiology market is projected to…
Indivi Secures CHF 15 Million to Advance Biomarker Discovery in Alzheimer’s and Neuroscience Drug Development Indivi, an independent TechBio company pioneering precision medicine solutions for neuroscience, today announced the successful…
Zai Lab Reports Promising Phase 1 Results for Zocilurtatug Pelitecan in Extensive-Stage Small Cell Lung Cancer, Launches Global Phase 3 Trial Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) has released…